AIM
OFIX icon

Acrospire Investment Management’s Orthofix Medical OFIX Stock Holding History

Acrospire Investment Management’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,505
Closed -$70K – 977
2017
Q2 		$70K Buy
1,505
+600
+66% +$24.9K 0.07% 530
2017
Q1 		$35K Sell
905
-5,199
-85% -$192K 0.03% 1244
2016
Q4 		$221K Buy
+6,104
New +$232K 0.09% 297

Other funds holding OFIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Acrospire Investment Management's OFIX Position: Q3 2017 in Review

Acrospire Investment Management sold out of Orthofix Medical (OFIX) in Q3 2017, closing a stake of 1,505 shares — an estimated $70K sold.

Acrospire Investment Management first reported a position in OFIX in Q4 2016 and held it in 3 quarters. The position peaked at $221K in Q4 2016. 147 funds tracked by Wall St. Rank hold OFIX as of Q3 2017.

  • Acrospire Investment Management reported no remaining Orthofix Medical position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 1,505 Orthofix Medical shares in Q3 2017, an estimated $70K.
  • Acrospire Investment Management first reported a position in Orthofix Medical in Q4 2016 and held it in 3 quarters.
  • Acrospire Investment Management's Orthofix Medical position peaked at $221K in Q4 2016.
  • 147 funds tracked by Wall St. Rank held Orthofix Medical as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.